Dendrimers functionalized with membrane-interacting peptides for viral inhibition
Open Access
- 1 February 2013
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. 8 (1) , 521-534
Abstract
This contribution reports the synthesis of a poly(amide)-based dendrimer functionalized at the termini with a membrane-interacting peptide derived from the herpes simplex virus (HSV) type 1 glycoprotein H, namely gH625-644. This peptide has been shown to interact with model membranes and to inhibit viral infectivity. The peptidodendrimer inhibits both HSV-1 and HSV-2 at a very early stage of the entry process, most likely through an interaction with the viral envelope glycoproteins; thus, preventing the virus from coming into close contact with cellular membranes, a prerequisite of viral internalization. The 50% inhibitory concentration was 100 and 300 nM against HSV-1 and HSV-2 respectively, with no evidence of cell toxicity at these concentrations. These results show that the functionalization of a dendrimer with the peptide sequence derived from an HSV glycoprotein shows promising inhibitory activity towards viruses of the Herpesviridae family.Keywords
This publication has 43 references indexed in Scilit:
- Structure and Orientation of the gH625–644 Membrane Interacting Region of Herpes Simplex Virus Type 1 in a Membrane Mimetic SystemBiochemistry, 2012
- Intracellular Delivery: Exploiting Viral Membranotropic PeptidesCurrent Drug Metabolism, 2012
- A peptide derived from herpes simplex virus type 1 glycoprotein H: membrane translocation and applications to the delivery of quantum dotsNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Role of membranotropic sequences from herpes simplex virus type I glycoproteins B and H in the fusion processBiochimica et Biophysica Acta (BBA) - Biomembranes, 2010
- Inhibition of Viral-Induced Membrane Fusion by PeptidesProtein & Peptide Letters, 2009
- Novel Targets for the Development of Anti-Herpes CompoundsInfectious Disorders - Drug Targets, 2007
- PAMAM Dendrimer-Based Multifunctional Conjugate for Cancer Therapy: Synthesis, Characterization, and FunctionalityBiomacromolecules, 2006
- Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex virusesAntiviral Research, 2005
- Functionalization of Single-Walled Carbon Nanotubes with Well-Defined Polystyrene by “Click” CouplingJournal of the American Chemical Society, 2005
- Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applicationsDrug Discovery Today, 2001